Welcome to Open Science
Contact Us
Home Books Journals Submission Open Science Join Us News
Acute Portal Vein Thrombosis a Case Report
Current Issue
Volume 3, 2015
Issue 2 (April)
Pages: 64-68   |   Vol. 3, No. 2, April 2015   |   Follow on         
Paper in PDF Downloads: 13   Since Aug. 28, 2015 Views: 1623   Since Aug. 28, 2015
Authors
[1]
Mountassir Moujahid, Departement of Surgery, University of Medicine and Pharmacy of Rabat, 5th Military Hospital, Guelmim, Morocco.
[2]
Hicham Iraqui, Departement of Surgery, University of Medicine and Pharmacy of Rabat, 5th Military Hospital, Guelmim, Morocco.
[3]
Mohamed Rhari, Departement of Radiology, University of Medicine and Pharmacy of Rabat, 5th Military Hospital, Guelmim, Morocco.
[4]
Khalid Chekoura, Departement of Anesthesia Resuscitation, University of Medicine and Pharmacy of Rabat, 5th Military Hospital, Guelmim, Morocco.
[5]
Issam Serghini, Departement of Anesthesia Resuscitation, University of Medicine and Pharmacy of Rabat, 5th Military Hospital, Guelmim, Morocco.
[6]
Moulay Hassan Tahiri, Departement of Surgery, University of Medicine and Pharmacy of Rabat, 5th Military Hospital, Guelmim, Morocco.
Abstract
The portal thrombosis vein is the most frequent cause of not cirrhotic high blood pressure portal. Its can be asymptomatic of fortuitous discovery or on the occasion of an abdominal pain during the acute phase or after appearance of a collateral venous circulation and formation of the portal cavernoma. The clinical diagnosis of portal thrombosis is difficult; it was made easy with the not invasive medical imaging. The spontaneous evolution is grave. The treatment is especially medical basing on anticoagulants allowing mostly a repermeabilisation of the thrombosis vessel. We report a case of acute portal thrombosis collaged in the 5th military hospital.
Keywords
Portal Thrombosis, Portal Vein, Portal Cavernoma, Diagnostic and Treatment, Anticoagulant Therapy
Reference
[1]
Condat B. Thrombosis of portal veina. GECB 2006 ; 10 : 1170-1176
[2]
Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. NEJM 2001; 345: 1683-8.
[3]
Condat B, Pessione F, Denninger MH, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 2000; 32:466-70.
[4]
Webb LJ, Sherlock S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med 1979; 192:627-39.
[5]
Impérato M, Moujahid M, Mennecier D, Béchade D, Duverger V, Farret O, Algayres J.-L, Baranger B .Acute superior mesenteric veinous thrombosis. Retrospective study of nine cases. Annals of surgery 2006, 131:595–600.
[6]
Sheen CL, Lamparelli H, Milne A, Green I, Ramage JK. Clinical features, diagnosis and outcome of acute portal vein thrombosis. Q J Med 2000; 93: 531-4.
[7]
Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, et al. Current outcome of portal vein thrombosis in adults : risk and benefit of anticoagulant therapy. Gastroenterology 2001; 120: 490-7.
[8]
Germain M A, Soukhni N, Bouzard D. mesenteric vein thrombosis compliquated by acute appendicitis. Annales de Chirurgie 2002, 127:381-4.
[9]
Trum JW, Valla D, Cohen G, et al. Bacteroides bacteriema of undetermined origin: strong association with portal vein thrombosis and cryptogenic pylephlebitis. Eur J Gastroenterol Hepatol 1993; 5:655-9.
[10]
Primignani M, Martinelli I, Bucciarelli P, Battaglioli T, Reati R, Fabris F, et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 2005; 41:603-8.
[11]
Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, et al. Cause of portal or hepatic venous thrombosis in adults : the role of multiple concurrent factors. Hepatology 2000 ; 31: 587-91.
[12]
Ueno N, Sasaki A, Tomiyama T, Tano S, Kimura K. Color Doppler ultrasonography in the diagnosis of cavernous transformation of the portal vein. J Clin Ultras 1997; 25: 227-33.
[13]
Dauzat M, Taourel P, Gallix B, et al. Ultrasonographic exploration of splanchnic circulation in men : physiologic and clinical interet. GECB 1998; 22:394-404.
[14]
Condat B, Vilgrain V, Asselah T, O'Toole D, Rufat P, Zappa M, et al. Portal cavernoma-associated cholangiopathy : a clinical and MR-cholangiography coupled with MR-portography imaging study. Hepatology 2003; 37: 1302-8.
[15]
Rahmouni A, Mathieu D, Golli M, Douek P, Anglade MC, Caillet H, et al. Value of CT and sonography in the conservative management of acute splenoportal and superior mesenteric venous thrombosis. J Gastroenterol Hepatol 1992; 17:135-40.
[16]
Kreft B, Strunk H, Flacke S, Wolff M, Conrad R, Gieseke J, et al. Detection of thrombosis in the portal venous system : comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography. Radiology 2000; 216: 86-92.
[17]
Valla D, Casadevall N, Huisse MG, Tulliez M, Grange JD, Muller O, et al. Etiology of portal vein thrombosis in adults: a prospective evaluation of primary myeloproliferative disorders. Gastroenterology 1988; 94: 1063-9.
[18]
Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004; 40: 736-41.
[19]
Condat B, Pessione F, Hillaire S, et al. Current outcome of portal vein thrombosis in adults : risk and benefit of anticoagulant therapy. Gastroenterology 2001; 120:490-7.
[20]
Chait Y, Condat B, Cazals-Hatem D, Rufat P, Atmani S, Chaoui D, et al. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol 2005 ; 129 : 553-60
[21]
Hassn AM, Al-Fallouji MA, Ouf TI, Saad R. Portal vein thrombosis following splenectomy. Br J Surg 2000; 87: 362-73.
[22]
James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144-8.
[23]
Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000; 96: 2364-8.
[24]
Joh JH, Kim DI. Mesenteric and portal vein thrombosis: treated with early initiation of anticoagulation. Eur J Vasc Endovasc Surg 2005; 29: 204-8.
[25]
Lagasse JP, Bahallah ML, Salem N, Debillon G, Labarrière D, Serve MP, et al. Acute portal system thrombosis. Treatment with alteplase and heparin or alone heparin in 10 patients. GECB 1997; 21:919-23.
[26]
Baril N, Wren S, Radin R, Ralls P, Stain S. The role of anticoagulation in pylephlebitis. Am J Surg 1996; 172:449-53.
[27]
Condat B, Valla D. Portal vein thrombosis: It is necessary to treat by anticoagulations? GECB 2001, 25, 5:507.
[28]
Hollingshead M, Burke CT, Mauro MA, Weeks SM, Dixon RG, Jaques PF. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol. 2005; 16 : 651-61.
[29]
Takahashi N,Kuroki K, Yanaga K. Percutaneous transhepatic mechanical thrombectomy for acute mesenteric venous thrombosis. J Endovasc Ther 2005, 12:508-11.
Open Science Scholarly Journals
Open Science is a peer-reviewed platform, the journals of which cover a wide range of academic disciplines and serve the world's research and scholarly communities. Upon acceptance, Open Science Journals will be immediately and permanently free for everyone to read and download.
CONTACT US
Office Address:
228 Park Ave., S#45956, New York, NY 10003
Phone: +(001)(347)535 0661
E-mail:
LET'S GET IN TOUCH
Name
E-mail
Subject
Message
SEND MASSAGE
Copyright © 2013-, Open Science Publishers - All Rights Reserved